Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase
- PMID: 3973595
- DOI: 10.1111/j.1471-4159.1985.tb12898.x
Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase
Abstract
The soluble form of human brain catechol-O-methyltransferase (EC 2.1.1.6, COMT) has been purified approximately 4,000-fold from a 250,000 X g supernatant solution. The purified enzyme exhibits a molecular weight near 27,500 and a pI value equal to approximately pH 5.0. Initial velocity and product inhibition studies are consistent with an ordered reaction mechanism for soluble COMT. Tropolone, a dead-end inhibitor, exhibited a competitive pattern of inhibition when dopamine (DA) was the varied substrate and an uncompetitive pattern when S-adenosyl-L-methionine (SAM) was the varied substrate. These observations strongly suggest that the soluble form of COMT from human brain catalyzes the O-methylation of catecholamines via an ordered reaction mechanism in which SAM is the leading substrate. Since the membrane-bound form of COMT catalyzes the O-methylation of catecholamines through an identical reaction mechanism, these data provide further evidence that two forms of COMT, while being localized in distinct subcellular compartments, are quite similar in their molecular structure.
Similar articles
-
Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase.Biochemistry. 1982 Apr 13;21(8):1740-2. doi: 10.1021/bi00537a006. Biochemistry. 1982. PMID: 7082642
-
Kinetic reaction mechanism for magnesium binding to membrane-bound and soluble catechol O-methyltransferase.Biochemistry. 1987 May 19;26(10):2955-8. doi: 10.1021/bi00384a042. Biochemistry. 1987. PMID: 3607001
-
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.Biochemistry. 1995 Apr 4;34(13):4202-10. doi: 10.1021/bi00013a008. Biochemistry. 1995. PMID: 7703232
-
Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Dec 5;781(1-2):359-72. doi: 10.1016/s1570-0232(02)00429-4. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12450669 Review.
-
Purification methods of mammalian catechol-O-methyltransferases.J Chromatogr B Biomed Appl. 1996 Sep 20;684(1-2):147-61. doi: 10.1016/0378-4347(96)00117-x. J Chromatogr B Biomed Appl. 1996. PMID: 8906471 Review.
Cited by
-
The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise.Br J Clin Pharmacol. 1993 Nov;36(5):451-6. doi: 10.1111/j.1365-2125.1993.tb00394.x. Br J Clin Pharmacol. 1993. PMID: 12959293 Free PMC article.
-
Central action of benserazide after COMT inhibition demonstrated in vivo by PET.J Neural Transm Gen Sect. 1991;85(1):11-7. doi: 10.1007/BF01244653. J Neural Transm Gen Sect. 1991. PMID: 1867835
-
Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):951-8. doi: 10.1042/bj2860951. Biochem J. 1992. PMID: 1417755 Free PMC article.
-
The mechanism of perturbation in monoamine metabolism by L-dopa therapy: in vivo and in vitro studies.J Neural Transm Gen Sect. 1992;90(3):183-97. doi: 10.1007/BF01250960. J Neural Transm Gen Sect. 1992. PMID: 1363050
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous